by Margy MacMillan
In this President’s Message, ASTCT President Margy MacMillan reflects on the mentors, colleagues, and relationships that shape careers in transplantation and cellular therapy. She highlights...
by Alex Kadhim
New research identifies NLRP6 as a critical regulator of donor T-cell activity after allogeneic hematopoietic cell transplantation, showing that loss of NLRP6 worsens acute graft-versus-host...
by Alex Kadhim
New research identifies donor-cell GATA3 as a key driver of intestinal graft-versus-host disease after hematopoietic cell transplantation, linking it to pathogenic T-cell activity, tissue damage,...
by Alex Kadhim
New research identifies a B cell–CD2 costimulatory pathway that enhances adoptive T-cell therapy, improving TIL and CAR-T cell function, metabolism, and tumor control in solid tumors. These...
by Alex Kadhim
Real-world Mayo Clinic data demonstrate the feasibility and effectiveness of tumor-infiltrating lymphocyte (TIL) therapy for metastatic melanoma, highlighting clinical outcomes, immune recovery,...
by ASTCT Talks
In this episode of ASTCT Talks, Dr. Nirali Shah welcomes Crystal Mackall, MD, the Ernest and Amelia Gallo Family Professor at Stanford University and a pioneer in immuno-oncology and cellular...